| Description | KKI 7 is a peptide analog. |
| Synonyms | KKI-7, N-Cyclohexylacetyl-phe-arg-ser-val-gln-NH2, KKI7 |
| molecular weight | 758.91 |
| Molecular formula | C36H58N10O8 |
| CAS | 113584-01-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Rebuffat P, Neri G, Bahçelioglu M, Malendowicz LK, Nussdorfer GG. Prolonged kallikrein inhibition does not affect the basal growth and secretory capacity of rat adrenal cortex, but enhances mineralo- and glucocorticoid response to ACTH and handling stress. Histol Histopathol. 2000 Apr;15(2):441-4. doi: 10.14670/HH-15.441. PubMed PMID: 10809362. 2. Burton J, Benetos A. The design of specific inhibitors of tissue kallikrein and their effect on the blood pressure of the rat. Adv Exp Med Biol. 1989;247B:9-13. PubMed PMID: 2610106. 3. Okunishi H, Spragg J, Burton J, Toda N. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides. Adv Exp Med Biol. 1989;247B:23-8. PubMed PMID: 2481944. 4. Okunishi H, Spragg J, Burton J. In vivo assay of specific kallikrein inhibitors. Agents Actions Suppl. 1987;22:381-90. PubMed PMID: 3481213. |